HSIC

Q: What is the price of Henry Schein (HSIC) today?

The price of Henry Schein (HSIC) today is US$ 63,17, with a variation of -9.81% compared to the last year. The price of Henry Schein (HSIC) started the year trading around US$ 69,20 and today it is at US$ 63,17. Follow the real-time price chart, the historical price of Henry Schein (HSIC), and stock data from Ibovespa and international markets.

Q: When does Henry Schein (HSIC) pay dividends?

Henry Schein (HSIC) did not distribute dividends in the last year.

Q: Henry Schein (HSIC) is it worth it?

Currently, Henry Schein (HSIC) is priced at US$ 63,17, with a P/E of 21,75%, representing a deviation of 19,09% from its historical average P/E. In the last year, the stock showed a variation of -9.81% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -9,81%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Henry Schein (HSIC)?

Investing in stocks of Henry Schein (HSIC) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Henry Schein (HSIC) yield today?

The yield of Henry Schein (HSIC) was -6,29% in the last month, -9,81% in the last year and 5,48% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Henry Schein (HSIC) today, the total investment would be US$ 6.317,00, based on the current price of US$ 63,17.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 5.697,30In 5 years: US$ 6.663,17In 10 years: 5.671,40It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Henry Schein Inc.

Price

US$ 63,17

variation (12m)

-9,81%

p/l

21,75

p/vp

1,67

DIVIDEND YIELD

0,00%

price HSIC

BVMF

HSIC

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of HSIC

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-6,29%

3 months

-13,96%

1 year

-9,81%

2 years

-12,94%

5 years

5,48%

10 years

-10,22%

real profitability

profitability minus inflation.

1 month

-6,29%

3 months

-14,28%

1 year

-13,77%

2 years

-20,54%

5 years

-22,05%

10 years

-46,25%

Indicators HSIC

check out the fundamentals of Henry Schein shares

P/E

21,75

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

0,64

Sector: 1,95 Industry: 2,78

P/BV

1,67

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

3,45%

Sector: -26,82% Industry: -52,06%

ROE

7,68%

Sector: -29,98% Industry: -40,51%

ROIC

6,02%

Sector: -411,56% Industry: -412,66%

NET MARGIN

2,93%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

31,35%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

5,76%

Sector: -23,36% Industry: -26,70%

P/EBITDA

8,64

Sector: 0,02 Industry: -2,09

P/EBIT

12,41

Sector: -1,26 Industry: -2,90

P/ASSET

0,75

Sector: 1,27 Industry: 1,41

BVPS

40,16

Sector: 3,73 Industry: 1,64

EPS

3,08

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,45

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

4,04%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-1,97%

Sector: - Industry: -

FAIR PRICE OF Henry Schein ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 63,17

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-16,49%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

HSIC indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%

comparison of HSIC with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History HSIC

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Henry Schein

Henry Schein Inc.

Average user rating I10

4.0 (4 people)

Estados Unidos

33 years

Foundation: 1992

1995

Year of debut on the stock exchange - 30 years

19.000

Employees

The Company Henry Schein Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 8,18 Billions, having a net worth of $ 4,90 Billions.

With a total of 19.000 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 12,84 Billions, which generated a profit in the amount of $ 376,00 Milhões.

As for its main indicators, the Company has a P/E ratio of 21,75, a P/BV ratio of 1,67 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker HSIC.

Market value

US$ 8,18 Billions

Net worth

US$ 4,90 Billions

US$ 4.899.000.000,00

Assets

US$ 10,91 Billions

US$ 10.906.000.000,00

Total Number of Shares

122,00 Milhões

122.000.000

Average Daily Trading Volume

US$ 1,75 Million

US$ 1.751.029,30

Sector

Health

Industry

Medical Supplies and Equipment

HSIC

HSIC revenue and profits

HSIC results

DRAG THE FRAME TO SEE MORE DATA

HSIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of Henry Schein (HSIC) today?

The price of Henry Schein (HSIC) today is US$ 63,17, with a variation of -9.81% compared to the last year. The price of Henry Schein (HSIC) started the year trading around US$ 69,20 and today it is at US$ 63,17. Follow the real-time price chart, the historical price of Henry Schein (HSIC), and stock data from Ibovespa and international markets.

When does Henry Schein (HSIC) pay dividends?

Henry Schein (HSIC) did not distribute dividends in the last year.

Henry Schein (HSIC) is it worth it?

Currently, Henry Schein (HSIC) is priced at US$ 63,17, with a P/E of 21,75%, representing a deviation of 19,09% from its historical average P/E. In the last year, the stock showed a variation of -9.81% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -9,81%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Henry Schein (HSIC)?

Investing in stocks of Henry Schein (HSIC) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Henry Schein (HSIC) yield today?

The yield of Henry Schein (HSIC) was -6,29% in the last month, -9,81% in the last year and 5,48% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of Henry Schein (HSIC) today, the total investment would be US$ 6.317,00, based on the current price of US$ 63,17.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 5.697,30
In 5 years: US$ 6.663,17
In 10 years: 5.671,40

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

HSIC

Henry Schein Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of HSIC

check out the fundamentals of Henry Schein shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Henry Schein

Henry Schein Inc.

Estados Unidos

33 years

1995

19.000

PROFIT X PRICE HSIC

HSIC results

HSIC cash flow

evolution of assets - HSIC

HSIC balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions